After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Amneal Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Amneal Pharmaceuticals Inc is $2.52B. A total of 1.3 million shares were traded on the day, compared to an average of 1.90M shares.
In the most recent transaction, Patel Gautam sold 94,906 shares of AMRX for 8.02 per share on Jun 16 ’25. After the transaction, the Director now owns 1,609,144 company shares. In a previous transaction on Jun 10 ’25, Patel Gautam sold 56,426 shares at 8.02 per share. AMRX shares that Director owns now total 1,704,050.
Among the insiders who sold shares, Shah Nikita disposed of 49,140 shares on May 16 ’25 at a per-share price of $7.58. This resulted in the Executive Vice President holding 388,929 shares of AMRX after the transaction. In another insider transaction, Shah Nikita bought 49,140 shares at $7.50 per share on May 16 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AMRX has a high of $9.48 and a low of $6.29.
As of this writing, AMRX has an earnings estimate of $0.17 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $0.18 per share and a lower estimate of $0.16.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AMRX’s latest balance sheet shows that the firm has $247.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.88B in debt and $677.24M in liabilities at the time. Its Book Value Per Share was -$0.42, while its Total Shareholder’s Equity was $366.97M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRX is Buy with a score of 5.00.
